en ENGLISH
eISSN: 2300-8660
ISSN: 0031-3939
Pediatria Polska - Polish Journal of Paediatrics
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Rada naukowa Bazy indeksacyjne Kontakt Zasady publikacji prac Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
Wyszukiwanie
Zasady redakcyjne
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

2/2020
vol. 95
 
Poleć ten artykuł:
Wyślij znajomemu
Udostępnij:
Artykuł oryginalny

The use of complementary and alternative medicine in Polish children with inflammatory bowel disease: single-centre survey-based study

Katarzyna Gerkowicz
1
,
Barbara Kołakowska
1
,
Monika Pawlak
1
,
Marcin Dziekiewicz
1

  1. Department of Paediatric Gastroenterology and Nutrition, Medical University of Warsaw, Warsaw, Poland
Pediatr Pol 2020; 95 (2): 106–111
DOI: https://doi.org/10.5114/polp.2020.97107
Data publikacji online: 2020/07/10
Plik artykułu:
- The use of complementary.pdf  [0.13 MB]
Pobierz cytowanie
 
Metryki PlumX:
 
1. Ben-Horin S, Kopylov U, Chowers Y. Optimizing anti-TNF treatments in inflammatory bowel disease. Autoimmun Rev 2014; 13: 24-30.
2. Gisbert JP, Panes J. Loss of response and requirement of infliximab dose intensification in Crohn’s disease: a review. Am J Gastroenterol 2009; 104: 760-767.
3. Beaugerie L, Rahier JF, Kirchgesner J. Predicting, Preventing, and Managing Treatment-related Complications in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol 2020; 18: 1324-1335.e2.
4. Ong F, Lee WS, Lin C, et al. Complementary and alternative medicine (CAM) practices and dietary patterns in children with inflammatory bowel disease in Singapore and Malaysia. Pediatr Neonatol 2018; 59: 494-500.
5. Levine A, Koletzko S, Turner D, et al. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr 2014; 58: 795-806.
6. Heuschkel R, Afzal N, Wuerth A, et al. Complementary medicine use in children and young adults with inflammatory bowel disease. Am J Gastroenterol 2002; 97: 382-388.
7. Nousiainen P, Merras-Salmio L, Aalto K, Kolho KL. Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis. BMC Complement Altern Med 2014; 14: 124.
8. Day AS, Whitten KE, Bohane TD. Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease. J Paediatr Child Health 2004; 40: 681-684.
9. Ceballos C, Bao R, Dunkin D, et al. Complementary and alternative medicine use at a single pediatric inflammatory bowel disease center. Gastroenterol Nurs 2014; 37: 265-271.
10. Serpico MR, Boyle BM, Kemper KJ, Kim SC. Complementary and Alternative Medicine Use in Children With Inflammatory Bowel Diseases: A Single-Center Survey. J Pediatr Gastroenterol Nutr 2016; 63: 651-657.
11. Wong AP, Clark AL, Garnett EA, et al. Use of complementary medicine in pediatric patients with inflammatory bowel disease: results from a multicenter survey. J Pediatr Gastroenterol Nutr 2009; 48: 55-60.
12. Uchida K, Inoue M, Otake K, et al. Complementary and alternative medicine use by Japanese children with pediatric surgical diseases. Open J Pediatr 2013; 3: 49-53.
13. Turner D, Ruemmele FM, Orlanski-Meyer E, et al. Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn’s and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2018; 67: 257-291.
14. Kemppainen LM, Kemppainen TT, Reippainen JA, et al. Use of complementary and alternative medicine in Europe: Health-related and sociodemographic determinants. Scand J Public Health 2018; 46: 448-455.
15. Oxelmark L, Lindberg A, Lofberg R, et al. Use of complementary and alternative medicine in Swedish patients with inflammatory bowel disease: a controlled study. Eur J Gastroenterol Hepatol 2016; 28: 1320-1328.
16. Fernandez A, Simian D, Quera R, et al. Complementary and alternative medicine in patients with inflammatory bowel disease: A survey performed in a tertiary center in Chile. Complement Ther Med 2018; 40: 77-82.
17. ISSP Research Group. International Social Survey Programme: Health and Health Care ISSP 2011. GESIS Data Archive CZDfV, 2015.
18. Weizman AV, Ahn E, Thanabalan R, et al. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease. Aliment Pharmacol Ther 2012; 35: 342-349.
19. Attwell K, Ward PR, Meyer SB, et al. “Do-it-yourself”: Vaccine rejection and complementary and alternative medicine (CAM). Soc Sci Med 2018; 196: 106-114.
20. Bleser WK, Elewonibi BR, Miranda PY, BeLue R. Complementary and Alternative Medicine and Influenza Vaccine Uptake in US Children. Pediatrics 2016; 138: e20154664.
Copyright: © 2020 Polish Society of Paediatrics. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.